|Minimum Order Quantity||1 Piece|
|Dose||As per the doctor prescribed|
|Packaging Size||10 ml|
Keytruda (pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Keytruda is used to treat:
advanced skin cancer (melanoma) that has spread to other parts of the body or cannot be surgically removed;
a certain type of non-small cell lung cancer, if your tumor has a specific genetic marker for which your doctor will test;
head and neck cancer that has spread to other parts of the body, or has come back after prior treatment;
classical Hodgkin lymphoma in adults and children;
a certain type of bladder and urinary tract cancer that has spread to other parts of the body or cannot be surgically removed; and
a type of cancer that laboratory testing proves to be a microsatellite instability-high or a mismatch repair deficiency solid tumor.
Keytruda is often given after other cancer medicine has been tried without success.
Keytruda was approved by the US Food and Drug Administrati
on (FDA) on an "accelerated" basis to treat lung cancer or head and neck cancer. In clinical studies, tumors responded to this medicine. However, it has not been shown that pembrolizumab can improve symptoms or lengthen survival time.
Keytruda can change the way your immune system works, which may cause certain side effects that can lead to serious medical problems.
Call your doctor at once if you have: chest pain, cough, shortness of breath, vision changes, tiredness, severe muscle pain or weakness, diarrhea and severe stomach pain, blood in your stools, bruising or bleeding, dark urine, yellowing of the skin or eyes, a hormonal disorder (frequent headaches, feeling light-headed, rapid heartbeats, a deeper voice, increased thirst or urination, feeling cold, weight gain or loss), or a change in the amount or color of your urine.